| Timeframe | Predicted Price | Past | Historical | Insight |
|---|---|---|---|---|
| Tomorrow | $29.19 ▲ +1.41% | Yesterday | $28.61 ▼ -0.59% | Tomorrow's Mineralys Therapeutics Inc. Common Stock (MLYS) setup is anchored to $28.78 and targets $29.19 (+1.41%). The near-term read is upside; watch $29.64 / $27.92 because daily realized volatility is about 7.29%. |
Tomorrow's Mineralys Therapeutics Inc. Common Stock (MLYS) setup is anchored to $28.78 and targets $29.19 (+1.41%). The near-term read is upside; watch $29.64 / $27.92 because daily realized volatility is about 7.29%. | ||||
| Week | $30.05 ▲ +4.40% | Last Week | $28.25 ▼ -1.85% | The 7-day Mineralys Therapeutics Inc. Common Stock model moves from $28.25 to $30.05 (+4.40%). It gives upside momentum context for this stock, so breaks around $29.64 / $27.92 matter more than a single tick. |
The 7-day Mineralys Therapeutics Inc. Common Stock model moves from $28.25 to $30.05 (+4.40%). It gives upside momentum context for this stock, so breaks around $29.64 / $27.92 matter more than a single tick. | ||||
| Month | $31.48 ▲ +9.37% | Last Month | $27.65 ▼ -3.94% | The 1-month Mineralys Therapeutics Inc. Common Stock target is $31.48 (+9.37%), compared with the live reference near $28.78. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. |
The 1-month Mineralys Therapeutics Inc. Common Stock target is $31.48 (+9.37%), compared with the live reference near $28.78. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. | ||||
| Year | $33.62 ▲ +16.82% | Last Year | $26.75 ▼ -7.07% | The 1-year Mineralys Therapeutics Inc. Common Stock scenario points to $33.62 (+16.82%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. |
The 1-year Mineralys Therapeutics Inc. Common Stock scenario points to $33.62 (+16.82%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. | ||||
| 5 Years | $38.65 ▲ +34.29% | 5 Years Ago | $24.64 ▼ -14.40% | The 5-year Mineralys Therapeutics Inc. Common Stock view is $38.65 (+34.29%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. |
The 5-year Mineralys Therapeutics Inc. Common Stock view is $38.65 (+34.29%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. | ||||
| Indicator | Value | Signal |
|---|---|---|
| Price | $28.78 | Mid |
| Daily Change | -4.29% | Below |
| Volatility Cap | 20.0% | Mid |
| Confidence | 66% | Above |
| Data Source | nasdaq-screener | Mid |
| Current | $28.78 | Daily Change | -4.29% |
| Market Cap | $2.37B | Source | nasdaq-screener |
Related ideas for internal navigation, grouped by stronger upside and weaker downside setups in the same market.